Kilitch Drugs (India) Limited (NSE:KILITCH)

Kilitch Drugs (India) Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	69.06	157.74	98.01	189.62	198.46	100.62
Short-Term Investments	508.29	529.65	495.65	501.09	393.31	472.34
Cash & Short-Term Investments	577.35	687.39	593.66	690.71	591.77	572.96
Cash Growth	-33.64%	15.79%	-14.05%	16.72%	3.28%	17.17%
Accounts Receivable	1,138	1,202	847.39	632.24	542.87	414.12
Other Receivables	-	0.33	0.32	0.34	0.22	0.2
Receivables	1,138	1,202	847.71	632.58	543.09	414.32
Inventory	122.21	119.88	215.78	55.82	24.07	52.88
Prepaid Expenses	-	2.65	1.98	0.86	1.58	0.5
Other Current Assets	260.86	209.93	80.04	79.97	103.53	100.39
Total Current Assets	2,099	2,222	1,739	1,460	1,264	1,141
Property, Plant & Equipment	2,024	1,887	928.19	481.2	473.58	464.03
Long-Term Investments	293	228.87	228.6	228.47	226.78	260.68
Goodwill	172.72	176.93	185.36	193.79	202.21	210.64
Other Intangible Assets	2.58	2.64	3.51	4.44	2.63	2.34
Long-Term Deferred Tax Assets	39.28	45.82	28.79	25.63	19.78	15.12
Other Long-Term Assets	12.91	14.13	14.22	7.15	6.21	4.63
Total Assets	4,643	4,577	3,128	2,401	2,195	2,098

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	689.95	796.47	541.57	255.89	408.75	428.69
Accrued Expenses	-	26.83	17.43	15.97	16.44	14.48
Short-Term Debt	399.84	301.06	216.54	316.47	221.94	204.32
Current Income Taxes Payable	80.99	65.66	66.86	53.05	40.39	43.96
Other Current Liabilities	58.48	25.99	0.7	0.78	1.22	1.34
Total Current Liabilities	1,229	1,216	843.1	642.16	688.73	692.79
Long-Term Debt	566.59	586.04	277.7	-	-	-
Pension & Post-Retirement Benefits	-	6.79	2.45	1.72	0.68	2.75
Other Long-Term Liabilities	6.79	-	-	-	-	-
Total Liabilities	1,803	1,809	1,123	643.88	689.41	695.55

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	349.62	349.62	160.82	160.82	155.82	155.82
Additional Paid-In Capital	-	765.33	466.84	466.84	383.26	383.26
Retained Earnings	-	1,569	1,267	1,000	854.29	749.81
Comprehensive Income & Other	2,536	112.62	128.32	134.95	122.6	101.97
Total Common Equity	2,885	2,797	2,023	1,763	1,516	1,391
Minority Interest	-45.06	-27.86	-18.71	-6.18	-10.17	12.07
Shareholders' Equity	2,840	2,769	2,005	1,757	1,506	1,403
Total Liabilities & Equity	4,643	4,577	3,128	2,401	2,195	2,098

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	966.43	887.09	494.24	316.47	221.94	204.32
Net Cash (Debt)	-389.08	-199.7	99.42	374.25	369.83	368.64
Net Cash Growth	-	-	-73.44%	1.19%	0.32%	8.11%
Net Cash Per Share	-11.12	-5.90	6.18	11.75	11.87	11.84
Filing Date Shares Outstanding	34.8	34.96	32.16	32.16	31.16	31.16
Total Common Shares Outstanding	34.8	34.96	32.16	32.16	31.16	31.16
Working Capital	869.4	1,006	896.06	817.77	575.3	448.25
Book Value Per Share	82.92	79.99	62.90	54.81	48.64	44.63
Tangible Book Value	2,710	2,617	1,834	1,565	1,311	1,178
Tangible Book Value Per Share	77.88	74.85	57.03	48.65	42.07	37.80
Land	-	116.92	86.78	86.78	86.13	86.13
Buildings	-	45.19	41.72	40.02	40.02	39.43
Machinery	-	645.82	621.67	568.69	561.19	529.87
Construction In Progress	-	1,400	472.95	59.65	36.19	31.61

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error